Absolute Investment Advisers LLC bought a new stake in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 273,694 shares of the company’s stock, valued at approximately $3,941,000.
A number of other hedge funds have also recently made changes to their positions in BMEZ. Jane Street Group LLC bought a new position in BlackRock Health Sciences Term Trust in the third quarter worth approximately $357,000. Kingswood Wealth Advisors LLC bought a new position in shares of BlackRock Health Sciences Term Trust in the 4th quarter worth $420,000. Oppenheimer & Co. Inc. lifted its stake in shares of BlackRock Health Sciences Term Trust by 0.6% during the 3rd quarter. Oppenheimer & Co. Inc. now owns 204,354 shares of the company’s stock worth $3,237,000 after purchasing an additional 1,153 shares during the last quarter. Brown Lisle Cummings Inc. boosted its position in BlackRock Health Sciences Term Trust by 6.2% during the third quarter. Brown Lisle Cummings Inc. now owns 36,513 shares of the company’s stock valued at $578,000 after purchasing an additional 2,128 shares in the last quarter. Finally, Sanctuary Advisors LLC purchased a new position in BlackRock Health Sciences Term Trust in the second quarter valued at about $3,179,000.
BlackRock Health Sciences Term Trust Stock Down 0.8 %
NYSE BMEZ opened at $16.46 on Monday. BlackRock Health Sciences Term Trust has a 12-month low of $14.27 and a 12-month high of $16.75. The firm’s fifty day simple moving average is $15.42 and its two-hundred day simple moving average is $15.64.
BlackRock Health Sciences Term Trust Announces Dividend
About BlackRock Health Sciences Term Trust
BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
Recommended Stories
- Five stocks we like better than BlackRock Health Sciences Term Trust
- Upcoming IPO Stock Lockup Period, Explained
- 3 Stocks to Gain From Trump’s Return-to-Office Mandate
- How to Read Stock Charts for Beginners
- Crane Stock Soars, But the Best Could Be Yet to Come: Here’s Why
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
Want to see what other hedge funds are holding BMEZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report).
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.